Ryuji Okamoto
Overview
Explore the profile of Ryuji Okamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
884
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubo T, Sugiura K, Tokita Y, Takano H, Takamisawa I, Takayama M, et al.
Heart
. 2025 Mar;
PMID: 40037766
Background: The Japanese Hypertrophic Cardiomyopathy Registry Study was designed to provide comprehensive, real-world insights into the clinical characteristics and management of hypertrophic cardiomyopathy (HCM) in Japan. Methods: This multicentre, prospective...
2.
Omori T, Fujimoto N, Nishida K, Sugiura E, Takasaki A, Nakamori S, et al.
JACC Case Rep
. 2025 Jan;
30(2):102810.
PMID: 39886413
can cause culture-negative endocarditis, and almost all antibiotics included in empirical therapy regimens for endocarditis are ineffective against this pathogen. We report a case of culture-negative endocarditis in which identification...
3.
Kagawa Y, Takafuji M, Fujita S, Kokawa T, Fukuma T, Ishida M, et al.
Int J Cardiovasc Imaging
. 2025 Jan;
41(3):419-426.
PMID: 39883382
Myocardial extracellular volume fraction (ECV) measured via MRI serves as a quantitative indicator of myocardial fibrosis. However, accurate measurement of ECV using MRI in the presence of AF is challenging....
4.
Taniguchi M, Okamoto R, Ito M, Goto I, Fujita S, Konishi K, et al.
PLoS One
. 2024 Dec;
19(12):e0315236.
PMID: 39630662
[This corrects the article DOI: 10.1371/journal.pone.0141130.].
5.
Tsuboya N, Sawada H, Mitani Y, Oshita H, Ohya K, Takeoka M, et al.
Cardiovasc Res
. 2024 Nov;
PMID: 39556088
Aims: We investigated whether the disruption of C-C motif chemokine receptor (CCR) 2 may attenuate the development of pulmonary arterial hypertension (PAH) in any rat models with the reversal of...
6.
Ikematsu H, Takara Y, Nishihara K, Kano Y, Owaki Y, Okamoto R, et al.
J Gastroenterol
. 2024 Oct;
60(1):77-85.
PMID: 39441401
Background: Fecal immunochemical tests are commonly performed for colorectal cancer screening. Instant fecal occult blood measurement in toilet bowel movements would improve convenience. Hyperspectral imaging (HSI) enables the nondestructive evaluation...
7.
Oguma T, Jino K, Nakahara K, Asada H, Fuchino K, Nagatani K, et al.
J Med Chem
. 2024 Aug;
67(16):14478-14492.
PMID: 39137033
Psychosis is a distressing symptom commonly occurring in people with dementia. To treat Parkinson's disease psychosis, pimavanserin (), a 5-HT receptor inverse agonist having minimal 5-HT receptor affinity and no...
8.
Makino M, Moriwaki K, Fujimoto N, Kirii Y, Mizutani H, Goto T, et al.
Circ Cardiovasc Imaging
. 2024 Jul;
17(12):e016905.
PMID: 39082131
No abstract available.
9.
Kobayashi H, Nakamura Y, Abe M, Nakamura T, Nozato Y, Izawa S, et al.
Hypertens Res
. 2024 Jul;
47(11):3035-3044.
PMID: 39075322
This study aims to evaluate the prevalence of unilateral hyperaldosteronism (UHA) and its clinical characteristics in patients with primary aldosteronism (PA), diagnosed using plasma aldosterone concentration (PAC) measured by chemiluminescent...
10.
Uno K, Fujimoto N, Ishiyama M, Okamoto R, Dohi K
Circ Rep
. 2024 Mar;
6(3):94-95.
PMID: 38464991
No abstract available.